Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts
about
Adoptive T-cell therapy for cancer: The era of engineered T cellsAnti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma.Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastomaEnhancing adoptive T cell immunotherapy with microRNA therapeutics.Immunotherapy in glioblastoma: emerging options in precision medicinePrioritization schema for immunotherapy clinical trials in glioblastoma.Advances in Immunotherapy for Glioblastoma Multiforme.The Dynamics of Interactions Among Immune and Glioblastoma Cells.Adoptive T-Cell Therapy for Solid Tumors.MicroRNA and extracellular vesicles in glioblastoma: small but powerful.Driving gene-engineered T cell immunotherapy of cancer.Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses.Cellular immunotherapy for malignant gliomas.Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them.The efficacy of chimeric antigen receptor (CAR) immunotherapy in animal models for solid tumors: A systematic review and meta-analysis.A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.Fluorine-19 nuclear magnetic resonance of chimeric antigen receptor T cell biodistribution in murine cancer model.CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors
P2860
Q26800611-B5CD6351-BDDA-4959-A450-148764BEA191Q33795137-9040733B-2F25-4238-882D-966D016CBB4DQ34478948-F4B1B323-F5EC-462D-AF0A-34BD0A44A317Q35163556-E8A4902A-D86B-43AE-90CA-D6B097D467EDQ35741739-F2F783A6-F554-4FAB-BE73-4073F6843F03Q36889204-39AA2501-2589-424D-92C9-40D70383838FQ37050960-EFA48C6F-B97F-434E-9739-FC111FC4FD11Q37078999-9A6E2271-0ED1-496E-BA1A-B02A23BE0085Q37680966-302777F6-2660-4877-BFB0-76F02676B2D8Q38557236-E534595D-3F29-480F-AE7F-4A77712E8D3CQ38754498-67D4539D-2FAD-4DD4-9C11-4929AD065486Q38770220-9CCD7845-3D97-4487-BE2E-3FACAEACA69DQ38777742-02828DDD-94BF-4DB7-95BD-13BD395F3E5BQ38829322-80057D17-9F99-471E-9524-B35CF385DC77Q38902169-FECC1515-FB78-40FA-A2C0-CD8A0437AA51Q38987239-F5918860-6B24-4A84-A008-DB990EAB911AQ45918458-D171A019-1C7E-48D0-BD0F-25A8BDCF617CQ45946525-03710C14-6AF2-49BF-9D9F-184722649B35Q46512368-FFA17B29-FE49-4DC3-BC67-763630970AA0Q47148959-A25EA634-B1B0-4264-9991-0188DFE66E13Q58606449-9CB1A38E-96BE-4CC2-938D-3F268ECE32C3
P2860
Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Expression of miR-17-92 enhanc ...... e bearing human GBM xenografts
@ast
Expression of miR-17-92 enhanc ...... e bearing human GBM xenografts
@en
type
label
Expression of miR-17-92 enhanc ...... e bearing human GBM xenografts
@ast
Expression of miR-17-92 enhanc ...... e bearing human GBM xenografts
@en
prefLabel
Expression of miR-17-92 enhanc ...... e bearing human GBM xenografts
@ast
Expression of miR-17-92 enhanc ...... e bearing human GBM xenografts
@en
P2093
P2860
P356
P1476
Expression of miR-17-92 enhanc ...... e bearing human GBM xenografts
@en
P2093
Akemi Kosaka
Atsushi Natsume
Carl H June
Hideho Okada
Kuniaki Tanahashi
Masasuke Ohno
Takayuki Ohkuri
P2860
P2888
P356
10.1186/2051-1426-1-21
P577
2013-12-16T00:00:00Z
P5875
P6179
1039604908